Acute and Chronic Experimental Trypanosoma cruzi Infection in the Rat. Response to Systemic Treatment with Recombinant Rat Interferon-Gamma

We examined the effects of recombinant rat inteferon-gamma (IFN-γ) injections on the parasitologic, serologic, immunologic and histopathologic features of acute and chronic experimental Trypanosoma cruzi (T. cruzi) infections in“l”rats. Upon infection at weaning, two rat groups were allocated to rec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:MICROBIOLOGY and IMMUNOLOGY 1995, Vol.39(4), pp.275-281
Hauptverfasser: Revelli, Silvia, Davila, Hector, Ferro, Maria E., Romero-Piffiguer, Marta, Musso, Orlando, Valenti, Jose, Bernabo, Jorge, Falcoff, Ernesto, Wietzerbin, Jeanne, Bottasso, Oscar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 281
container_issue 4
container_start_page 275
container_title MICROBIOLOGY and IMMUNOLOGY
container_volume 39
creator Revelli, Silvia
Davila, Hector
Ferro, Maria E.
Romero-Piffiguer, Marta
Musso, Orlando
Valenti, Jose
Bernabo, Jorge
Falcoff, Ernesto
Wietzerbin, Jeanne
Bottasso, Oscar
description We examined the effects of recombinant rat inteferon-gamma (IFN-γ) injections on the parasitologic, serologic, immunologic and histopathologic features of acute and chronic experimental Trypanosoma cruzi (T. cruzi) infections in“l”rats. Upon infection at weaning, two rat groups were allocated to receive a 20-day cycle of IFN-γ injections, 20, 000IU/rat each, which started at 1, and 7 days post-infection (pi). Treatment with IFN-γ, initiated at either 1 or 7 days pi, resulted in comparatively lower peak parasitemias (P
doi_str_mv 10.1111/j.1348-0421.1995.tb02201.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77470433</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1492634982</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5931-12103ede0c2f8e7269d41daeaafb636ffd73e5f7ed05494a8c3b8893014610793</originalsourceid><addsrcrecordid>eNqVkt9u0zAUhyMEGmXwCEgWQoibBP9LHHPFVHVdpQ3QVgR3luucUJfEKbartbwCL41Lq4orEL6IrZzvfCfKz1n2guCCpPVmVRDG6xxzSgoiZVnEBaYUk2L7IBudSg-zEWZ1mZcVxo-zJyGsMKaC1vwsOxNVSSgno-znhdlEQNo1aLz0g7MGTbZr8LYHF3WH5n631m4IQ6-R8ZsfFs1cCybawSHrUFwCutWxQLcQ1oMLgOKA7nYhQp9Mcw867kXo3sZlYszQL6zT6UVqSqYIvoU0NZ_qvtdPs0et7gI8O-7n2afLyXx8lV9_mM7GF9e5KSUjOaEEM2gAG9rWIGglG04aDVq3i4pVbdsIBmUroMEll1zXhi3qWjJMeEWwkOw8e3Xwrv3wfQMhqt4GA12nHQyboITgAnPG_gmSSspaiiqBr_8OckkrxmVNE_r2gBo_hOChVev0s7XfKYLVPl21UvsI1T5CtU9XHdNV29T8_Dhns-ihObUe40z1l8e6DkZ3rdfO2HDCWFlWpMIJe3fA7m0Hu__4AHUzu_l9TIrJQbEKUX-Fk0P7aE0Hqk83yhIphGJS8cODivJUN0vtFbjkyQ8em-7M9g_NN1UJlho-v5-qj1_urqZ8StQl-wXm3uqf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1492634982</pqid></control><display><type>article</type><title>Acute and Chronic Experimental Trypanosoma cruzi Infection in the Rat. Response to Systemic Treatment with Recombinant Rat Interferon-Gamma</title><source>MEDLINE</source><source>J-STAGE (Japan Science &amp; Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><source>Open Access Titles of Japan</source><source>Alma/SFX Local Collection</source><creator>Revelli, Silvia ; Davila, Hector ; Ferro, Maria E. ; Romero-Piffiguer, Marta ; Musso, Orlando ; Valenti, Jose ; Bernabo, Jorge ; Falcoff, Ernesto ; Wietzerbin, Jeanne ; Bottasso, Oscar</creator><creatorcontrib>Revelli, Silvia ; Davila, Hector ; Ferro, Maria E. ; Romero-Piffiguer, Marta ; Musso, Orlando ; Valenti, Jose ; Bernabo, Jorge ; Falcoff, Ernesto ; Wietzerbin, Jeanne ; Bottasso, Oscar</creatorcontrib><description>We examined the effects of recombinant rat inteferon-gamma (IFN-γ) injections on the parasitologic, serologic, immunologic and histopathologic features of acute and chronic experimental Trypanosoma cruzi (T. cruzi) infections in“l”rats. Upon infection at weaning, two rat groups were allocated to receive a 20-day cycle of IFN-γ injections, 20, 000IU/rat each, which started at 1, and 7 days post-infection (pi). Treatment with IFN-γ, initiated at either 1 or 7 days pi, resulted in comparatively lower peak parasitemias (P&lt;0.02) but in similar levels of anti-T. cruzi circulating antibodies and serum IFN-γ activities. The latter appeared significantly increased during acute infection whereas biologically active tumor necrosis factor was virtually undetectable in serum from infected rats regardless of whether they had been given IFN-γ or not. The prevalence of chronic focal myocarditis in IFN-γ-treated infected rats showed no differences with respect to the one recorded in control-infected counterparts. The inverse CD4/CD8 ratio of spleen and lymph node T cells that usually accompanies chronic infection was reversed by IFN-γ. Mononuclear cells carrying class II I-A and I-E molecules, that were found to have increased at both compartments, appeared also modified upon IFN-γ treatment with an overincrease of I-A-positive cells, and a normalization of I-E-bearing cells.</description><identifier>ISSN: 0385-5600</identifier><identifier>EISSN: 1348-0421</identifier><identifier>DOI: 10.1111/j.1348-0421.1995.tb02201.x</identifier><identifier>PMID: 7651241</identifier><identifier>CODEN: MIIMDV</identifier><language>eng</language><publisher>Tokyo: Blackwell Publishing Ltd</publisher><subject>Acute Disease ; AIDS/HIV ; Animals ; Antibodies, Protozoan - analysis ; Biological and medical sciences ; CD4-CD8 Ratio ; Chagas Disease - immunology ; Chagas Disease - pathology ; Chagas Disease - therapy ; Chronic Disease ; Class II antigens ; Disease Models, Animal ; Experimental protozoal diseases and models ; Histocompatibility Antigens Class II - immunology ; Infectious diseases ; Interferon-gamma ; Interferon-gamma - analysis ; Interferon-gamma - therapeutic use ; Lymph Nodes - cytology ; Male ; Medical sciences ; Myocarditis ; Myocarditis - etiology ; Myocarditis - pathology ; Parasitemia - immunology ; Parasitemia - pathology ; Parasitemia - therapy ; Parasitic diseases ; Prevalence ; Protozoal diseases ; Rats ; Recombinant Proteins ; Spleen - cytology ; T-cell subsets ; T-Lymphocyte Subsets - immunology ; Trypanosoma cruzi ; Trypanosoma cruzi - drug effects ; Trypanosoma cruzi - immunology ; Tumor Necrosis Factor-alpha - analysis</subject><ispartof>MICROBIOLOGY and IMMUNOLOGY, 1995, Vol.39(4), pp.275-281</ispartof><rights>Center for Academic Publications Japan</rights><rights>owned by Center for Academic Publications Japan (Publisher)</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5931-12103ede0c2f8e7269d41daeaafb636ffd73e5f7ed05494a8c3b8893014610793</citedby><cites>FETCH-LOGICAL-c5931-12103ede0c2f8e7269d41daeaafb636ffd73e5f7ed05494a8c3b8893014610793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,1877,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3556160$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7651241$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Revelli, Silvia</creatorcontrib><creatorcontrib>Davila, Hector</creatorcontrib><creatorcontrib>Ferro, Maria E.</creatorcontrib><creatorcontrib>Romero-Piffiguer, Marta</creatorcontrib><creatorcontrib>Musso, Orlando</creatorcontrib><creatorcontrib>Valenti, Jose</creatorcontrib><creatorcontrib>Bernabo, Jorge</creatorcontrib><creatorcontrib>Falcoff, Ernesto</creatorcontrib><creatorcontrib>Wietzerbin, Jeanne</creatorcontrib><creatorcontrib>Bottasso, Oscar</creatorcontrib><title>Acute and Chronic Experimental Trypanosoma cruzi Infection in the Rat. Response to Systemic Treatment with Recombinant Rat Interferon-Gamma</title><title>MICROBIOLOGY and IMMUNOLOGY</title><addtitle>Microbiology and Immunology</addtitle><description>We examined the effects of recombinant rat inteferon-gamma (IFN-γ) injections on the parasitologic, serologic, immunologic and histopathologic features of acute and chronic experimental Trypanosoma cruzi (T. cruzi) infections in“l”rats. Upon infection at weaning, two rat groups were allocated to receive a 20-day cycle of IFN-γ injections, 20, 000IU/rat each, which started at 1, and 7 days post-infection (pi). Treatment with IFN-γ, initiated at either 1 or 7 days pi, resulted in comparatively lower peak parasitemias (P&lt;0.02) but in similar levels of anti-T. cruzi circulating antibodies and serum IFN-γ activities. The latter appeared significantly increased during acute infection whereas biologically active tumor necrosis factor was virtually undetectable in serum from infected rats regardless of whether they had been given IFN-γ or not. The prevalence of chronic focal myocarditis in IFN-γ-treated infected rats showed no differences with respect to the one recorded in control-infected counterparts. The inverse CD4/CD8 ratio of spleen and lymph node T cells that usually accompanies chronic infection was reversed by IFN-γ. Mononuclear cells carrying class II I-A and I-E molecules, that were found to have increased at both compartments, appeared also modified upon IFN-γ treatment with an overincrease of I-A-positive cells, and a normalization of I-E-bearing cells.</description><subject>Acute Disease</subject><subject>AIDS/HIV</subject><subject>Animals</subject><subject>Antibodies, Protozoan - analysis</subject><subject>Biological and medical sciences</subject><subject>CD4-CD8 Ratio</subject><subject>Chagas Disease - immunology</subject><subject>Chagas Disease - pathology</subject><subject>Chagas Disease - therapy</subject><subject>Chronic Disease</subject><subject>Class II antigens</subject><subject>Disease Models, Animal</subject><subject>Experimental protozoal diseases and models</subject><subject>Histocompatibility Antigens Class II - immunology</subject><subject>Infectious diseases</subject><subject>Interferon-gamma</subject><subject>Interferon-gamma - analysis</subject><subject>Interferon-gamma - therapeutic use</subject><subject>Lymph Nodes - cytology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Myocarditis</subject><subject>Myocarditis - etiology</subject><subject>Myocarditis - pathology</subject><subject>Parasitemia - immunology</subject><subject>Parasitemia - pathology</subject><subject>Parasitemia - therapy</subject><subject>Parasitic diseases</subject><subject>Prevalence</subject><subject>Protozoal diseases</subject><subject>Rats</subject><subject>Recombinant Proteins</subject><subject>Spleen - cytology</subject><subject>T-cell subsets</subject><subject>T-Lymphocyte Subsets - immunology</subject><subject>Trypanosoma cruzi</subject><subject>Trypanosoma cruzi - drug effects</subject><subject>Trypanosoma cruzi - immunology</subject><subject>Tumor Necrosis Factor-alpha - analysis</subject><issn>0385-5600</issn><issn>1348-0421</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkt9u0zAUhyMEGmXwCEgWQoibBP9LHHPFVHVdpQ3QVgR3luucUJfEKbartbwCL41Lq4orEL6IrZzvfCfKz1n2guCCpPVmVRDG6xxzSgoiZVnEBaYUk2L7IBudSg-zEWZ1mZcVxo-zJyGsMKaC1vwsOxNVSSgno-znhdlEQNo1aLz0g7MGTbZr8LYHF3WH5n631m4IQ6-R8ZsfFs1cCybawSHrUFwCutWxQLcQ1oMLgOKA7nYhQp9Mcw867kXo3sZlYszQL6zT6UVqSqYIvoU0NZ_qvtdPs0et7gI8O-7n2afLyXx8lV9_mM7GF9e5KSUjOaEEM2gAG9rWIGglG04aDVq3i4pVbdsIBmUroMEll1zXhi3qWjJMeEWwkOw8e3Xwrv3wfQMhqt4GA12nHQyboITgAnPG_gmSSspaiiqBr_8OckkrxmVNE_r2gBo_hOChVev0s7XfKYLVPl21UvsI1T5CtU9XHdNV29T8_Dhns-ihObUe40z1l8e6DkZ3rdfO2HDCWFlWpMIJe3fA7m0Hu__4AHUzu_l9TIrJQbEKUX-Fk0P7aE0Hqk83yhIphGJS8cODivJUN0vtFbjkyQ8em-7M9g_NN1UJlho-v5-qj1_urqZ8StQl-wXm3uqf</recordid><startdate>19950101</startdate><enddate>19950101</enddate><creator>Revelli, Silvia</creator><creator>Davila, Hector</creator><creator>Ferro, Maria E.</creator><creator>Romero-Piffiguer, Marta</creator><creator>Musso, Orlando</creator><creator>Valenti, Jose</creator><creator>Bernabo, Jorge</creator><creator>Falcoff, Ernesto</creator><creator>Wietzerbin, Jeanne</creator><creator>Bottasso, Oscar</creator><general>Blackwell Publishing Ltd</general><general>Center For Academic Publications Japan</general><general>Center for Academic Publications Japan</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>M7N</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19950101</creationdate><title>Acute and Chronic Experimental Trypanosoma cruzi Infection in the Rat. Response to Systemic Treatment with Recombinant Rat Interferon-Gamma</title><author>Revelli, Silvia ; Davila, Hector ; Ferro, Maria E. ; Romero-Piffiguer, Marta ; Musso, Orlando ; Valenti, Jose ; Bernabo, Jorge ; Falcoff, Ernesto ; Wietzerbin, Jeanne ; Bottasso, Oscar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5931-12103ede0c2f8e7269d41daeaafb636ffd73e5f7ed05494a8c3b8893014610793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Acute Disease</topic><topic>AIDS/HIV</topic><topic>Animals</topic><topic>Antibodies, Protozoan - analysis</topic><topic>Biological and medical sciences</topic><topic>CD4-CD8 Ratio</topic><topic>Chagas Disease - immunology</topic><topic>Chagas Disease - pathology</topic><topic>Chagas Disease - therapy</topic><topic>Chronic Disease</topic><topic>Class II antigens</topic><topic>Disease Models, Animal</topic><topic>Experimental protozoal diseases and models</topic><topic>Histocompatibility Antigens Class II - immunology</topic><topic>Infectious diseases</topic><topic>Interferon-gamma</topic><topic>Interferon-gamma - analysis</topic><topic>Interferon-gamma - therapeutic use</topic><topic>Lymph Nodes - cytology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Myocarditis</topic><topic>Myocarditis - etiology</topic><topic>Myocarditis - pathology</topic><topic>Parasitemia - immunology</topic><topic>Parasitemia - pathology</topic><topic>Parasitemia - therapy</topic><topic>Parasitic diseases</topic><topic>Prevalence</topic><topic>Protozoal diseases</topic><topic>Rats</topic><topic>Recombinant Proteins</topic><topic>Spleen - cytology</topic><topic>T-cell subsets</topic><topic>T-Lymphocyte Subsets - immunology</topic><topic>Trypanosoma cruzi</topic><topic>Trypanosoma cruzi - drug effects</topic><topic>Trypanosoma cruzi - immunology</topic><topic>Tumor Necrosis Factor-alpha - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Revelli, Silvia</creatorcontrib><creatorcontrib>Davila, Hector</creatorcontrib><creatorcontrib>Ferro, Maria E.</creatorcontrib><creatorcontrib>Romero-Piffiguer, Marta</creatorcontrib><creatorcontrib>Musso, Orlando</creatorcontrib><creatorcontrib>Valenti, Jose</creatorcontrib><creatorcontrib>Bernabo, Jorge</creatorcontrib><creatorcontrib>Falcoff, Ernesto</creatorcontrib><creatorcontrib>Wietzerbin, Jeanne</creatorcontrib><creatorcontrib>Bottasso, Oscar</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>MICROBIOLOGY and IMMUNOLOGY</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Revelli, Silvia</au><au>Davila, Hector</au><au>Ferro, Maria E.</au><au>Romero-Piffiguer, Marta</au><au>Musso, Orlando</au><au>Valenti, Jose</au><au>Bernabo, Jorge</au><au>Falcoff, Ernesto</au><au>Wietzerbin, Jeanne</au><au>Bottasso, Oscar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute and Chronic Experimental Trypanosoma cruzi Infection in the Rat. Response to Systemic Treatment with Recombinant Rat Interferon-Gamma</atitle><jtitle>MICROBIOLOGY and IMMUNOLOGY</jtitle><addtitle>Microbiology and Immunology</addtitle><date>1995-01-01</date><risdate>1995</risdate><volume>39</volume><issue>4</issue><spage>275</spage><epage>281</epage><pages>275-281</pages><issn>0385-5600</issn><eissn>1348-0421</eissn><coden>MIIMDV</coden><abstract>We examined the effects of recombinant rat inteferon-gamma (IFN-γ) injections on the parasitologic, serologic, immunologic and histopathologic features of acute and chronic experimental Trypanosoma cruzi (T. cruzi) infections in“l”rats. Upon infection at weaning, two rat groups were allocated to receive a 20-day cycle of IFN-γ injections, 20, 000IU/rat each, which started at 1, and 7 days post-infection (pi). Treatment with IFN-γ, initiated at either 1 or 7 days pi, resulted in comparatively lower peak parasitemias (P&lt;0.02) but in similar levels of anti-T. cruzi circulating antibodies and serum IFN-γ activities. The latter appeared significantly increased during acute infection whereas biologically active tumor necrosis factor was virtually undetectable in serum from infected rats regardless of whether they had been given IFN-γ or not. The prevalence of chronic focal myocarditis in IFN-γ-treated infected rats showed no differences with respect to the one recorded in control-infected counterparts. The inverse CD4/CD8 ratio of spleen and lymph node T cells that usually accompanies chronic infection was reversed by IFN-γ. Mononuclear cells carrying class II I-A and I-E molecules, that were found to have increased at both compartments, appeared also modified upon IFN-γ treatment with an overincrease of I-A-positive cells, and a normalization of I-E-bearing cells.</abstract><cop>Tokyo</cop><pub>Blackwell Publishing Ltd</pub><pmid>7651241</pmid><doi>10.1111/j.1348-0421.1995.tb02201.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0385-5600
ispartof MICROBIOLOGY and IMMUNOLOGY, 1995, Vol.39(4), pp.275-281
issn 0385-5600
1348-0421
language eng
recordid cdi_proquest_miscellaneous_77470433
source MEDLINE; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese; Open Access Titles of Japan; Alma/SFX Local Collection
subjects Acute Disease
AIDS/HIV
Animals
Antibodies, Protozoan - analysis
Biological and medical sciences
CD4-CD8 Ratio
Chagas Disease - immunology
Chagas Disease - pathology
Chagas Disease - therapy
Chronic Disease
Class II antigens
Disease Models, Animal
Experimental protozoal diseases and models
Histocompatibility Antigens Class II - immunology
Infectious diseases
Interferon-gamma
Interferon-gamma - analysis
Interferon-gamma - therapeutic use
Lymph Nodes - cytology
Male
Medical sciences
Myocarditis
Myocarditis - etiology
Myocarditis - pathology
Parasitemia - immunology
Parasitemia - pathology
Parasitemia - therapy
Parasitic diseases
Prevalence
Protozoal diseases
Rats
Recombinant Proteins
Spleen - cytology
T-cell subsets
T-Lymphocyte Subsets - immunology
Trypanosoma cruzi
Trypanosoma cruzi - drug effects
Trypanosoma cruzi - immunology
Tumor Necrosis Factor-alpha - analysis
title Acute and Chronic Experimental Trypanosoma cruzi Infection in the Rat. Response to Systemic Treatment with Recombinant Rat Interferon-Gamma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T05%3A05%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20and%20Chronic%20Experimental%20Trypanosoma%20cruzi%20Infection%20in%20the%20Rat.%20Response%20to%20Systemic%20Treatment%20with%20Recombinant%20Rat%20Interferon-Gamma&rft.jtitle=MICROBIOLOGY%20and%20IMMUNOLOGY&rft.au=Revelli,%20Silvia&rft.date=1995-01-01&rft.volume=39&rft.issue=4&rft.spage=275&rft.epage=281&rft.pages=275-281&rft.issn=0385-5600&rft.eissn=1348-0421&rft.coden=MIIMDV&rft_id=info:doi/10.1111/j.1348-0421.1995.tb02201.x&rft_dat=%3Cproquest_cross%3E1492634982%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1492634982&rft_id=info:pmid/7651241&rfr_iscdi=true